A review of national guidelines for management of COPD in Europe.

2.50
Hdl Handle:
http://hdl.handle.net/11287/595869
Title:
A review of national guidelines for management of COPD in Europe.
Authors:
Miravitlles, M; Vogelmeier, C; Roche, N; Halpin, David M; Cardoso, J; Chuchalin, A G; Kankaanranta, H; Sandström, T; Śliwiński, P; Zatloukal, J; Blasi, F
Abstract:
The quality of care can be improved by the development and implementation of evidence-based treatment guidelines. Different national guidelines for chronic obstructive pulmonary disease (COPD) exist in Europe and relevant differences may exist among them.This was an evaluation of COPD treatment guidelines published in Europe and Russia in the past 7 years. Each guideline was reviewed in detail and information about the most important aspects of patient diagnosis, risk stratification and pharmacotherapy was extracted following a standardised process. Guidelines were available from the Czech Republic, England and Wales, Finland, France, Germany, Italy, Poland, Portugal, Russia, Spain and Sweden. The treatment goals, criteria for COPD diagnosis, consideration of comorbidities in treatment selection and support for use of long-acting bronchodilators, were similar across treatment guidelines. There were differences in measures used for stratification of disease severity, consideration of patient phenotypes, criteria for the use of inhaled corticosteroids and recommendations for other medications (e.g. theophylline and mucolytics) in addition to bronchodilators.There is generally good agreement on treatment goals, criteria for diagnosis of COPD and use of long-acting bronchodilators as the cornerstone of treatment among guidelines for COPD management in Europe and Russia. However, there are differences in the definitions of patient subgroups and other recommended treatments.
Citation:
A review of national guidelines for management of COPD in Europe. 2016, 47 (2):625-37 Eur. Respir. J.
Publisher:
European Respiratory Society
Journal:
The European respiratory journal
Issue Date:
Feb-2016
URI:
http://hdl.handle.net/11287/595869
DOI:
10.1183/13993003.01170-2015
PubMed ID:
26797035
Additional Links:
http://www.ncbi.nlm.nih.gov/pmc/articles/pmid/26797035/
Note:
This article is freely available via Open Access. Click on the 'Additional Link' above to access the full-text from the publisher's site.
Type:
Journal Article; Guideline; Review
Language:
en
ISSN:
1399-3003
Appears in Collections:
Respiratory Medicine; 2016 RD&E publications

Full metadata record

DC FieldValue Language
dc.contributor.authorMiravitlles, Men
dc.contributor.authorVogelmeier, Cen
dc.contributor.authorRoche, Nen
dc.contributor.authorHalpin, David Men
dc.contributor.authorCardoso, Jen
dc.contributor.authorChuchalin, A Gen
dc.contributor.authorKankaanranta, Hen
dc.contributor.authorSandström, Ten
dc.contributor.authorŚliwiński, Pen
dc.contributor.authorZatloukal, Jen
dc.contributor.authorBlasi, Fen
dc.date.accessioned2016-02-08T16:02:35Zen
dc.date.available2016-02-08T16:02:35Zen
dc.date.issued2016-02en
dc.identifier.citationA review of national guidelines for management of COPD in Europe. 2016, 47 (2):625-37 Eur. Respir. J.en
dc.identifier.issn1399-3003en
dc.identifier.pmid26797035en
dc.identifier.doi10.1183/13993003.01170-2015en
dc.identifier.urihttp://hdl.handle.net/11287/595869en
dc.description.abstractThe quality of care can be improved by the development and implementation of evidence-based treatment guidelines. Different national guidelines for chronic obstructive pulmonary disease (COPD) exist in Europe and relevant differences may exist among them.This was an evaluation of COPD treatment guidelines published in Europe and Russia in the past 7 years. Each guideline was reviewed in detail and information about the most important aspects of patient diagnosis, risk stratification and pharmacotherapy was extracted following a standardised process. Guidelines were available from the Czech Republic, England and Wales, Finland, France, Germany, Italy, Poland, Portugal, Russia, Spain and Sweden. The treatment goals, criteria for COPD diagnosis, consideration of comorbidities in treatment selection and support for use of long-acting bronchodilators, were similar across treatment guidelines. There were differences in measures used for stratification of disease severity, consideration of patient phenotypes, criteria for the use of inhaled corticosteroids and recommendations for other medications (e.g. theophylline and mucolytics) in addition to bronchodilators.There is generally good agreement on treatment goals, criteria for diagnosis of COPD and use of long-acting bronchodilators as the cornerstone of treatment among guidelines for COPD management in Europe and Russia. However, there are differences in the definitions of patient subgroups and other recommended treatments.en
dc.language.isoenen
dc.publisherEuropean Respiratory Societyen
dc.relation.urlhttp://www.ncbi.nlm.nih.gov/pmc/articles/pmid/26797035/en
dc.rightsArchived with thanks to The European respiratory journalen
dc.subjectWessex Classification Subject Headings::Respiratory medicineen
dc.titleA review of national guidelines for management of COPD in Europe.en
dc.typeJournal Articleen
dc.typeGuidelineen
dc.typeReviewen
dc.identifier.journalThe European respiratory journalen
dc.description.noteThis article is freely available via Open Access. Click on the 'Additional Link' above to access the full-text from the publisher's site.en
dc.type.versionPublisheden

Related articles on PubMed

All Items in RD&E Research Repository are protected by copyright, with all rights reserved, unless otherwise indicated.